Published in Thorax on April 01, 2001
Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis. Thorax (2007) 2.60
Association between pulmonary function and sputum biomarkers in cystic fibrosis. Am J Respir Crit Care Med (2007) 2.03
Comparison of Airway and Systemic Malondialdehyde Levels for Assessment of Oxidative Stress in Cystic Fibrosis. Lung (2015) 2.00
Potential role of high-mobility group box 1 in cystic fibrosis airway disease. Am J Respir Crit Care Med (2008) 1.62
High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis. Proc Natl Acad Sci U S A (2006) 1.47
Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis. Sci Transl Med (2012) 1.40
Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearance. Clin Diagn Lab Immunol (2002) 1.35
Fast detection of volatile organic compounds from bacterial cultures by secondary electrospray ionization-mass spectrometry. J Clin Microbiol (2010) 1.20
Determining cystic fibrosis-affected lung microbiology: comparison of spontaneous and serially induced sputum samples by use of terminal restriction fragment length polymorphism profiling. J Clin Microbiol (2009) 1.13
The microbiome in pediatric cystic fibrosis patients: the role of shared environment suggests a window of intervention. Microbiome (2014) 0.91
Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis. Infect Drug Resist (2011) 0.90
Robust detection of P. aeruginosa and S. aureus acute lung infections by secondary electrospray ionization-mass spectrometry (SESI-MS) breathprinting: from initial infection to clearance. J Breath Res (2013) 0.89
Sputum tobramycin concentrations in cystic fibrosis patients with repeated administration of inhaled tobramycin. J Aerosol Med Pulm Drug Deliv (2012) 0.88
Mechanisms and applications of hypertonic saline. J R Soc Med (2011) 0.87
Pseudomonas aeruginosa serological analysis in young children with cystic fibrosis diagnosed through newborn screening. Pediatr Pulmonol (2010) 0.84
Sputum induction improves detection of pathogens in children with cystic fibrosis. Pediatr Pulmonol (2015) 0.81
Using bacterial biomarkers to identify early indicators of cystic fibrosis pulmonary exacerbation onset. Expert Rev Mol Diagn (2011) 0.81
Exhaled breath condensate pH in patients with cystic fibrosis. Inflamm Res (2012) 0.80
The efficiency of sputum cell counts in cystic fibrosis. Can Respir J (2007) 0.80
Purifying the impure: sequencing metagenomes and metatranscriptomes from complex animal-associated samples. J Vis Exp (2014) 0.78
The effect of α1-antitrypsin deficiency combined with increased bacterial loads on chronic obstructive pulmonary disease pharmacotherapy: A prospective, parallel, controlled pilot study. J Adv Res (2016) 0.75
Correlation between sputum and bronchoalveolar lavage fluid cultures. J Clin Microbiol (2014) 0.75
Hypertonic Saline as a Useful Tool for Sputum Induction and Pathogen Detection in Cystic Fibrosis. Lung (2017) 0.75
Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med (1996) 5.69
Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med (1996) 5.53
Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis (1998) 4.82
Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax (1992) 4.30
Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination. Eur Respir J (1996) 2.46
Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. Am Rev Respir Dis (1993) 2.34
The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med (1997) 2.28
Spontaneous and induced sputum to measure indices of airway inflammation in asthma. Am J Respir Crit Care Med (1996) 1.97
TNF-alpha, IL-8, soluble ICAM-1, and neutrophils in sputum of cystic fibrosis patients. Pediatr Pulmonol (1996) 1.70
Current understanding of the inflammatory process in cystic fibrosis: onset and etiology. Pediatr Pulmonol (1997) 1.68
Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease. Thorax (1998) 1.64
Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis. Pediatr Pulmonol (1996) 1.59
Cellular characteristics of sputum from patients with asthma and chronic bronchitis. Thorax (1989) 1.40
Some technical factors influencing the induction of sputum for cell analysis. Eur Respir J (1995) 1.36
Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis. Am J Respir Crit Care Med (1996) 1.33
Sputum ECP levels correlate with parameters of airflow obstruction. Am Rev Respir Dis (1992) 1.27
Changes in the cellular profile of induced sputum after allergen-induced asthmatic responses. Am Rev Respir Dis (1992) 1.24
Analysis of cellular and biochemical constituents of induced sputum after allergen challenge: a method for studying allergic airway inflammation. J Allergy Clin Immunol (1994) 1.22
Hyperosmolarity-induced interleukin-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein kinase. Am J Respir Crit Care Med (1999) 1.10
Fractional analysis of sequential induced sputum samples during sputum induction: evidence that different lung compartments are sampled at different time points. J Allergy Clin Immunol (1999) 1.06
The effect of salt water on alveolar epithelial barrier function. Am J Respir Crit Care Med (1994) 0.94
Sensitivity and specificity of oropharyngeal suction versus bronchoalveolar lavage in identifying respiratory tract pathogens in children with chronic pulmonary infection. Pediatr Pulmonol (1995) 0.86
Comparison of sputum processing techniques in cystic fibrosis. Pediatr Pulmonol (1996) 0.85
Radiographic changes in acute exacerbations of cystic fibrosis in adults: a pilot study. AJR Am J Roentgenol (1994) 0.81
Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science (1999) 3.98
Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration. J Virol (1997) 2.65
Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers. J Pediatr (1988) 2.60
Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol (2001) 2.24
Identification and detection of Stenotrophomonas maltophilia by rRNA-directed PCR. J Clin Microbiol (2000) 1.90
A permeability barrier as a mechanism of chloramphenicol resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1985) 1.84
Insulin-like growth factor ligands, receptors, and binding proteins in cancer. J Pathol (2005) 1.73
Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis. Thorax (2004) 1.71
Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis. J Clin Invest (1996) 1.70
Calcineurin is required for skeletal muscle hypertrophy. J Biol Chem (1999) 1.65
Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation. J Bacteriol (2008) 1.63
Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis. Am Rev Respir Dis (1993) 1.63
Disposition of drugs in cystic fibrosis. III. Acetaminophen. Clin Pharmacol Ther (1991) 1.59
A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease. Hum Gene Ther (2001) 1.58
Serum and lower respiratory tract drug concentrations after tobramycin inhalation in young children with cystic fibrosis. J Pediatr (2001) 1.56
Evaluation of reference dilution test methods for antimicrobial susceptibility testing of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis. J Clin Microbiol (1999) 1.51
Interaction of prenatal exposure to cigarettes and MAOA genotype in pathways to youth antisocial behavior. Mol Psychiatry (2009) 1.50
Empowering the individual with ALS at the end-of-life: disease-specific advance care planning. Muscle Nerve (2001) 1.46
Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis. J Clin Microbiol (1993) 1.45
Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis. J Clin Microbiol (2001) 1.43
Septic arthritis of the temporomandibular joint: review of the literature and report of two cases in children. Int J Oral Maxillofac Surg (1993) 1.41
Too much ethics, not enough medicine: clarifying the role of clinical expertise for the clinical ethics consultant. J Clin Ethics (2001) 1.34
Gastric spirillosis in beagles. Am J Vet Res (1987) 1.32
Establishment of immortalized alveolar type II epithelial cell lines from adult rats. In Vitro Cell Dev Biol Anim (1996) 1.31
Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment. J Infect Dis (2000) 1.27
Activities of tobramycin and six other antibiotics against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother (1999) 1.26
Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol (1999) 1.21
Intermediates in membrane fusion and bilayer/nonbilayer phase transitions imaged by time-resolved cryo-transmission electron microscopy. Biophys J (1989) 1.21
Absence of health insurance is associated with decreased life expectancy in patients with cystic fibrosis. Am J Respir Crit Care Med (1997) 1.15
Patient-reported respiratory symptoms in cystic fibrosis. J Cyst Fibros (2009) 1.13
Retinal degeneration slow (rds) in mouse results from simple insertion of a t haplotype-specific element into protein-coding exon II. Genomics (1995) 1.12
Time-resolved cryotransmission electron microscopy. J Electron Microsc Tech (1990) 1.07
Laryngeal tuberculosis. J Otolaryngol (1993) 1.07
Prevalence of allergic bronchopulmonary aspergillosis and atopy in adult patients with cystic fibrosis. Chest (1996) 1.07
Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection. Thorax (2013) 1.06
Active tuberculosis after isoniazid chemoprophylaxis of Southeast Asian refugees. Am Rev Respir Dis (1986) 1.06
Effect of heat delivery and extraction on airway conductance in normal and in asthmatic subjects. Am Rev Respir Dis (1985) 1.05
Cloning and expression in Escherichia coli of a gene encoding nonenzymatic chloramphenicol resistance from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1986) 1.01
Factor analysis of the Condom Use Self-Efficacy Scale among multicultural college students. Health Educ Res (2000) 1.00
Fifteen years of experience with bacterial meningitis. Pediatr Infect Dis J (1999) 0.99
Influence of body size and gender on control of ventilation. J Appl Physiol (1985) (1986) 0.97
Osteoporosis in patients with cystic fibrosis. Clin Chest Med (1998) 0.95
Accuracy and cost of antibiotic susceptibility testing of mixed morphotypes of Pseudomonas aeruginosa. J Clin Microbiol (1994) 0.95
Effect of recombinant human platelet-activating factor-acetylhydrolase on allergen-induced asthmatic responses. Am J Respir Crit Care Med (2000) 0.95
Infection control in cystic fibrosis: practical recommendations for the hospital, clinic, and social settings. Am J Infect Control (2000) 0.94
Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial. Contemp Clin Trials (2013) 0.94
Young at heart: understanding the unique psychosocial adjustment of young implantable cardioverter defibrillator recipients. Pacing Clin Electrophysiol (2001) 0.93
Retroviral vectors efficiently transduce basal and secretory airway epithelial cells in vitro resulting in persistent gene expression in organotypic culture. Hum Gene Ther (1996) 0.90
Chloramphenicol accumulation by Haemophilus influenzae. Antimicrob Agents Chemother (1987) 0.89
Complications of indwelling catheters in cystic fibrosis: a 10-year review. Chest (2000) 0.89
Evolution of Pseudomonas aeruginosa virulence in infected patients revealed in a Dictyostelium discoideum host model. Clin Microbiol Infect (2011) 0.87
Covariates of tooth-brushing frequency in low-income African Americans from grades 5 to 8. Pediatr Dent (2007) 0.87
Pregnancy in patients with cystic fibrosis. Clin Obstet Gynecol (1996) 0.86
Variable severity of pulmonary disease in adults with identical cystic fibrosis mutations. Chest (1992) 0.85
Pediatric urinary tract infection. Diagnosis, classification, and significance. Pediatr Clin North Am (1987) 0.85
Malignant nerve-sheath tumor with divergent and glandular differentiation in a dog: a case report. Vet Pathol (2002) 0.85
Life-threatening theophylline toxicity is not predictable by serum levels. Chest (1987) 0.84
Western frontier physician taking pulse. J Altern Complement Med (1999) 0.83
Safety of repeated intermittent courses of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis. J Pediatr (1997) 0.83
Cleaning home nebulizers used by patients with cystic fibrosis: is rinsing with tap water enough? J Hosp Infect (2001) 0.82
Safety of aerosolized INS 365 in patients with mild to moderate cystic fibrosis: results of a phase I multi-center study. Pediatr Pulmonol (2001) 0.82
Radiographic changes in acute exacerbations of cystic fibrosis in adults: a pilot study. AJR Am J Roentgenol (1994) 0.81
A rare continual flowering strategy and its influence on offspring quality in a gynodioecious plant. Am J Bot (2001) 0.81
A temperature-jump device for time-resolved cryo-transmission electron microscopy. Microsc Res Tech (1992) 0.80
Nocardia asteroides septic arthritis in a healthy child. Pediatr Infect Dis J (1999) 0.80
No evidence for chromosomal mosaicism in multiple tissues of 10 patients with 45, XO Turner syndrome. Clin Genet (1979) 0.79
Effect of tobramycin on protein synthesis in 2-deoxystreptamine aminoglycoside-resistant clinical isolates of Haemophilus influenzae. Antimicrob Agents Chemother (1986) 0.79
Predictors of drug-resistant Mycobacterium tuberculosis. Am Rev Respir Dis (1984) 0.79
The complications of diaphyseal fractures in dogs: a review of 100 cases. J Small Anim Pract (1980) 0.79
Open pulmonary biopsy. Nineteen-year experience with 416 consecutive operations. Chest (1976) 0.78
Andrew Taylor Still, M.D.: founder of osteopathy. J Altern Complement Med (1997) 0.78
Burkholderia cepacia--a transmissible cystic fibrosis pathogen. J Pediatr (2001) 0.78
Pseudomonal pericarditis complicating cystic fibrosis. Pediatr Pulmonol (1999) 0.77
Hydrotherapy. J Altern Complement Med (1997) 0.77
Low incidence of citrullinemia carriers among dairy cattle of the United States. J Dairy Sci (1993) 0.76
Humid air increases airway resistance in asthmatic subjects. West J Med (1988) 0.76
Nasal lavage. J Otolaryngol (1992) 0.76
Bleomycin-induced pulmonary fibrosis in a patient with rheumatoid arthritis. A possible synergistic effect? West J Med (1989) 0.75
Decalin-induced nephrotoxicity: light and electron microscopic examination of the effects of oral dosing on the development of kidney lesions in the rat. Food Chem Toxicol (1987) 0.75
Terminal sedation. N Engl J Med (1998) 0.75
Comparison study of home catheter cleaning methods. Rehabil Nurs (1995) 0.75
The equivalence of compressor pressure-flow relationships with respect to jet nebulizer aerosolization characteristics. J Aerosol Med (2001) 0.75
A hypertrophied bronchial circulatory system may participate in gas exchange. Lancet (1998) 0.75
Ear examination: the otoscope. J Otolaryngol (1993) 0.75
Pulmonary function in subjects at the extremes of stature. Am Rev Respir Dis (1985) 0.75
Cystic fibrosis. Curr Opin Pulm Med (1996) 0.75
Primary meningococcal pneumonia diagnosed by pleural fluid culture. Am J Dis Child (1986) 0.75
Massage therapy. J Altern Complement Med (2000) 0.75
Changes in visceral yolk sac ultrastructure after exposure of rat embryos to selected teratogens in vitro. Toxicol In Vitro (1990) 0.75
Cardiac asystole during an hypoxic drive study in a normal subject. Chest (1984) 0.75
NHS review. Emasculating the profession. BMJ (1989) 0.75
Preparation and characterization of a reconstituted stratum corneum film as a model membrane for skin transport. Arch Dermatol Res (1988) 0.75
Successful lung transplantation in spite of cystic fibrosis-associated liver disease: a case series. J Heart Lung Transplant (1997) 0.75
Characterization of the early ultrastructural and biochemical events occurring in dichloromethane diphosphonate nephrotoxicity. Toxicol Pathol (1990) 0.75
Viscosity effect on the structural compactness of latex flocs formed under weak depletion attractions. J Colloid Interface Sci (2002) 0.75
Some personality attributes of volunteers and of nonvolunteers for psychological experimentation. J Soc Psychol (1974) 0.75
Ozena. J Otolaryngol (1993) 0.75
Update on clinical trials of cystic fibrosis. Curr Opin Pulm Med (1997) 0.75
New and emerging therapies for pulmonary complications of cystic fibrosis. Drugs (2001) 0.75